NO882242D0 - Stabilisering av biologiske og farmasoeytiske produkter under varmeinaktivering av virale- og bakterielle forurensninger. - Google Patents

Stabilisering av biologiske og farmasoeytiske produkter under varmeinaktivering av virale- og bakterielle forurensninger.

Info

Publication number
NO882242D0
NO882242D0 NO882242A NO882242A NO882242D0 NO 882242 D0 NO882242 D0 NO 882242D0 NO 882242 A NO882242 A NO 882242A NO 882242 A NO882242 A NO 882242A NO 882242 D0 NO882242 D0 NO 882242D0
Authority
NO
Norway
Prior art keywords
biological
viral
stabilization
under heat
pharmaceutical products
Prior art date
Application number
NO882242A
Other languages
English (en)
Other versions
NO882242L (no
NO176234B (no
NO176234C (no
Inventor
Fred Feldman
Mark S Klekamp
Michael E Hrinda
Arthur B Shaw
Sudhish Chandra
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma filed Critical Armour Pharma
Publication of NO882242D0 publication Critical patent/NO882242D0/no
Publication of NO882242L publication Critical patent/NO882242L/no
Publication of NO176234B publication Critical patent/NO176234B/no
Publication of NO176234C publication Critical patent/NO176234C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO882242A 1987-05-22 1988-05-20 Fremgangsmåte for inaktivering av patogener i et biologisk eller et farmasöytisk materiale NO176234C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5292687A 1987-05-22 1987-05-22

Publications (4)

Publication Number Publication Date
NO882242D0 true NO882242D0 (no) 1988-05-20
NO882242L NO882242L (no) 1988-11-23
NO176234B NO176234B (no) 1994-11-21
NO176234C NO176234C (no) 1995-03-01

Family

ID=21980809

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882242A NO176234C (no) 1987-05-22 1988-05-20 Fremgangsmåte for inaktivering av patogener i et biologisk eller et farmasöytisk materiale

Country Status (11)

Country Link
EP (1) EP0292003B1 (no)
JP (2) JP2605102B2 (no)
AT (1) ATE103185T1 (no)
AU (1) AU606159B2 (no)
CA (1) CA1337688C (no)
DE (1) DE3888571T2 (no)
ES (1) ES2061554T3 (no)
FI (1) FI95778C (no)
IL (1) IL86417A (no)
NO (1) NO176234C (no)
NZ (1) NZ224740A (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3619565A1 (de) * 1986-06-11 1987-12-17 Behringwerke Ag Verfahren zur herstellung einer pasteurisierten immunglobulinpraeparation
EP0440509A3 (en) * 1990-02-02 1991-12-18 Common Services Agency Novel cell growth medium components and process for producing same
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
WO1994013329A1 (de) * 1992-12-16 1994-06-23 Immuno Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
HRP940645A2 (en) * 1993-10-06 1996-12-31 Immuno Ag Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
EP2921180B1 (en) 1999-02-22 2019-08-14 University of Connecticut Albumin-free factor VIII formulations
CA2611200A1 (en) * 2005-06-06 2006-12-14 Novo Nordisk A/S Stabilised il-21 compositions
DE102006008613A1 (de) * 2006-02-24 2007-08-30 Dade Behring Marburg Gmbh Stabilisierte Zubereitungen von Serin-Endopeptidasen, deren Herstellung und Verwendung
NZ593190A (en) 2008-11-07 2013-01-25 Baxter Int Factor viii formulations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53142593A (en) * 1977-12-12 1978-12-12 Green Cross Corp:The Stabilization of urokinase by heating
EP0035204B2 (en) * 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
US4379085A (en) * 1982-05-14 1983-04-05 American National Red Cross Heat stabilization of plasma proteins
US4470968A (en) * 1983-01-13 1984-09-11 Miles Laboratories, Inc. Pasteurized therapeutically active blood coagulation factor concentrates
JPS59134730A (ja) * 1983-01-20 1984-08-02 Green Cross Corp:The 血液凝固第８因子の加熱処理法
CA1213827A (en) * 1983-04-29 1986-11-12 Ricardo H. Landaburu Process for pasteurizing fibronectin
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
JPS61189228A (ja) * 1985-02-19 1986-08-22 Nippon Sekijiyuujishiya 血液凝固第８因子製剤の製法
JPH0825902B2 (ja) * 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
US4632980A (en) * 1985-04-03 1986-12-30 Immunologics Ozone decontamination of blood and blood products
JPS6289628A (ja) * 1985-09-11 1987-04-24 Green Cross Corp:The 人フイブリノゲン製剤の加熱処理法
JPS6281327A (ja) * 1985-10-04 1987-04-14 Green Cross Corp:The 人トロンビン製剤の加熱処理方法

Also Published As

Publication number Publication date
FI882387L (fi) 1988-11-23
JPH09118634A (ja) 1997-05-06
DE3888571D1 (de) 1994-04-28
NO882242L (no) 1988-11-23
EP0292003B1 (en) 1994-03-23
ES2061554T3 (es) 1994-12-16
NZ224740A (en) 1990-01-29
NO176234B (no) 1994-11-21
NO176234C (no) 1995-03-01
IL86417A (en) 1992-09-06
EP0292003A2 (en) 1988-11-23
FI95778C (fi) 1996-03-25
JPS649937A (en) 1989-01-13
CA1337688C (en) 1995-12-05
DE3888571T2 (de) 1994-08-11
FI882387A0 (fi) 1988-05-20
FI95778B (fi) 1995-12-15
IL86417A0 (en) 1988-11-15
ATE103185T1 (de) 1994-04-15
AU606159B2 (en) 1991-01-31
JP2605102B2 (ja) 1997-04-30
EP0292003A3 (en) 1990-06-13
AU1664288A (en) 1988-11-24
JP2879427B2 (ja) 1999-04-05

Similar Documents

Publication Publication Date Title
NO882242L (no) Stabilisering av biologiske og farmasoeytiske produkter under varmeinaktivering av virale og bakterielle forurensninger.
DE69432351D1 (de) Verfahren zum sterilisieren von produkten
EP0691270A3 (en) Device and method for sterilizing and packaging blister packs in boxes
ZA887195B (en) Novel process
GR3017535T3 (en) Live vaccines.
DE68903558D1 (de) Verfahren zur inaktivierung von viren.
ATE72127T1 (de) Sterilisationsverfahren.
SE8803071L (sv) Bakteriebehandling foer att bevara hoekvalitet genom att tillaegga genius bacillus mikroorganismer
EP0633786A4 (en) METHOD FOR INACTIVATING VIRAL AND BACTERIAL BLOOD IMPURITIES.
PT86393A (en) Process for the preparation of therapeutical and prophylatic agents containig pp4 of tissue protein and for the purification of these proteins
EP0247998A3 (en) Process for the inactivation of propagating filtrable pathogenic microbes
FI914026A0 (fi) Foerfarande foer framstaellning av genomsynlig reglerad mjoelkvassleprotein och reglerad mjoelkvassleproteinprodukt.
AU3876793A (en) Process for the inactivation of viruses in preparations of proteins
DK0457035T3 (da) Fremgangsmåde til inaktivering af den biologiske aktivitet af DNA
DE3485610D1 (de) Verfahren zur erhaltung und vermehrung von defekten, nicht-infektioesen virusgenomen.
EP0249167A3 (en) Process for preparing a pasteurized immunoglobulin preparation
ES8608892A1 (es) Procedimiento para esterilizar materiales de envasado para el envasado aseptico de zumo de frutas y de vino
DE3574675D1 (de) Verfahren zum sterilisieren von rekombinantem mikroorganismus.
SE8700136L (sv) Forfarande for behandling av amfotera aminosyror
Digeronimo Sterilization of packaging material.
FI883226L (fi) Kontrollindikator foer gassterilisering.

Legal Events

Date Code Title Description
MK1K Patent expired